Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges

Transthyretin amyloid cardiomyopathy: Treatment pipeline, clinical trials, and challenges

Transthyretin amyloid cardiomyopathy (ATTR-CM) is potentially a fatal disease characterized by abnormal buildup of amyloid fibrils primarily in the heart causing progressive heart failure. It is categorized into two subtypes-hereditary ATTR and wild type ATTR. Previously, no treatment is available,...

Full description

Bibliographic Details
Main Authors: Sweety Sharma, Bhawna Sharma
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Public Health and Primary Care
Subjects:
amyloid
amyloidosis
cardiomyopathy
transthyretin
transthyretin amyloid cardiomyopathy
Online Access:http://www.jphpc.org/article.asp?issn=2772-3666;year=2021;volume=2;issue=2;spage=32;epage=37;aulast=Sharma

Internet

http://www.jphpc.org/article.asp?issn=2772-3666;year=2021;volume=2;issue=2;spage=32;epage=37;aulast=Sharma

Similar Items